Merck & Co., Inc. (MRK)
115.44
-0.18
(-0.15%)
USD |
NYSE |
Mar 16, 16:00
115.07
-0.36
(-0.32%)
After-Hours: 16:55
Merck Market Cap : 285.40B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 197.46B |
| Biogen, Inc. | 26.89B |
| Gilead Sciences, Inc. | 180.29B |
| Regeneron Pharmaceuticals, Inc. | 79.99B |
| Moderna, Inc. | 21.06B |
Market Cap Related Metrics
| PE Ratio | 15.87 |
| PS Ratio | 4.458 |
| PEG Ratio | 1.975 |
| Price to Book Value | 5.425 |
| Price to Free Cash Flow | 23.42 |
| Price | 115.44 |
| Earnings Yield | 6.30% |
| PEGY Ratio | 1.459 |
| Operating PE Ratio | 10.84 |
| Normalized PE Ratio | 13.35 |